X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Research & Development

Vantage Cancer Care Network Collaborates with Alliance Cancer Specialists, PC, to Expand the Delivery of High-Quality Cancer Care across Philadelphia

Content Team by Content Team
16th January 2018
in Research & Development
Vantage Cancer Care Network Collaborates with Alliance Cancer Specialists, PC, to Expand the Delivery of High-Quality Cancer Care across Philadelphia

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Vantage Cancer Care Network (VCCN), a leader in value-based integrated cancer care, announced an agreement with Alliance Cancer Specialists, PC, to expand the delivery of high-quality oncology care across the Philadelphia region. Under the agreement, 21 oncologists across 11 locations are joining VCCN and will collaborate on providing seamless and efficient oncology care.

“We are privileged to join the Vantage Cancer Care Network in order to more closely align with like-minded physicians striving to improve quality and outcomes while lowering the overall cost of cancer care,” said Ann Marie Edwards, chief executive officer, Alliance Cancer Specialists, PC.

Physicians will benefit from VCCN’s expertise on value-based agreements, analytics tools, and process-improvement insights to help them achieve savings and quality outcomes in a value-based environment. As a result of this collaboration, VCCN will have a network of nearly 100 oncologists across 28 locations in the Philadelphia region.

“VCCN is pleased to join forces with Alliance Cancer Specialists,” said John Iacuone, MD, president & chief clinical officer, Vantage Cancer Care Network. “Alliance and VCCN are committed to working together so citizens of Philadelphia have access to high-quality cancer care and a superior patient experience, all while providing value to our health plan colleagues.”

About Alliance Cancer Specialists, PC
At Alliance, we’ve aligned the largest community-based team of cancer experts in Southeastern Pennsylvania. We offer quality cancer care that provides every advantage to help control and cure the disease.

Our approach guarantees new patients will be seen within 48 hours by one of our cancer experts. After evaluation, our team will provide a well-coordinated, tailored plan with diagnostic testing, the most powerful and precise treatment options, and compassionate care. With our combined strength and broad expertise, we provide the highest level of service to our patients and referring physicians in the Delaware Valley. To learn more visit www.alliancecancer.com

About Vantage Cancer Care Network
Vantage Cancer Care Network (VCCN) was founded to optimize cancer outcomes in a value-based, patient-centered care environment by developing cancer care networks to deliver appropriate, personalized and cost-effective care. VCCN is providing solutions to meet the growing needs of the oncology marketplace such as Carelytics™, a data management and reporting analytics tool. VCCN works with various oncology specialties to manage patient care through evidence-based treatment modalities. VCCN is supported by McKesson Specialty Health, a division of McKesson Corporation empowering the community patient care delivery system by helping community practices advance the science, technology and quality of care.

PR Contact
Claire Crye, VCCN
Claire.Crye@McKesson.com

Tina Bellanca, Alliance Cancer Specialists, PC
TBellanca@lmiadvertising.com

Previous Post

START & Sarah Cannon Partner to Advance Therapies for Patients with Cancer

Next Post

iMedrix Announces General Availability of KardioScreen, a CE certified, Connected ECG Device for Universal Use

Related Posts

Robots and AI in Drug
Articles

Robots and AI in Drug Discovery Are Transforming Medicine

29th May 2025
Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Next in Pharma 2025 Innovations
Articles

Next in Pharma 2025: Innovations Shaping the Future

28th May 2025
Insights

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

27th May 2025
Insights

AstraZeneca Eyes Acquisition To Develop Cell Therapies

24th March 2025
Drug Development

Continuous Bioprocessing Market to Surge by 2028

7th March 2025
Next Post

iMedrix Announces General Availability of KardioScreen, a CE certified, Connected ECG Device for Universal Use

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In